Compare · DSGR vs STE
DSGR vs STE
Side-by-side comparison of Distribution Solutions Group Inc. (DSGR) and STERIS plc (Ireland) (STE): market cap, price performance, sector, and recent activity on the wire.
Summary
- DSGR operates in Consumer Discretionary, while STE operates in Health Care - the two are in different parts of the market.
- STE is the larger of the two at $21.75B, about 17.2x DSGR ($1.26B).
- Over the past year, DSGR is up 4.0% and STE is down 1.5% - DSGR leads by 5.6 points.
- STE has hit the wire 3 times in the past 4 weeks while DSGR has been quiet.
- STE has more recent analyst coverage (16 ratings vs 1 for DSGR).
- Company
- Distribution Solutions Group Inc.
- STERIS plc (Ireland)
- Price
- $27.46+0.38%
- $221.72-0.76%
- Market cap
- $1.26B
- $21.75B
- 1M return
- +3.58%
- -0.80%
- 1Y return
- +4.03%
- -1.52%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 0
- 3
- Recent ratings
- 1
- 16
STERIS plc (Ireland)
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. This segment offers its products and services to acute care hospitals and other healthcare settings. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The company is based in Dublin, Ireland.
Latest DSGR
- SEC Form 4 filed by Knutson Ronald J
- SEC Form DEF 14A filed by Distribution Solutions Group Inc.
- SEC Form PRE 14A filed by Distribution Solutions Group Inc.
- Distribution Solutions Group Confirms Receipt of Unsolicited Non-Binding Proposal from LKCM Headwater Investments
- Amendment: SEC Form SCHEDULE 13D/A filed by Distribution Solutions Group Inc.
- Director Zamarripa Robert bought $297,220 worth of shares (14,000 units at $21.23), increasing direct ownership by 42% to 47,105 units (SEC Form 4)
- Distribution Solutions Group Announces Acquisition of Eastern Valve & Control Specialties
- SEC Form 10-K filed by Distribution Solutions Group Inc.
- Distribution Solutions Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Distribution Solutions Group Announces 2025 Full Year and Fourth Quarter Results
Latest STE
- STERIS to Host a Conference Call for Fiscal 2026 Fourth Quarter and Full Year Results on May 12, 2026
- Teleflex Announces Governance Updates
- SEC Form 8-K filed by STERIS plc (Ireland)
- Amendment: SEC Form SCHEDULE 13G/A filed by STERIS plc (Ireland)
- Director Feldmann Cynthia L exercised 3,098 units of Ordinary Shares at a strike of $152.32 and sold $734,877 worth of Ordinary Shares (3,098 units at $237.21) (SEC Form 4)
- SEC Form 144 filed by STERIS plc (Ireland)
- SEC Form 10-Q filed by STERIS plc (Ireland)
- STERIS plc (Ireland) filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- STERIS Announces Financial Results for Fiscal 2026 Third Quarter
- STERIS Announces Dividend of $0.63 per share